These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23917397)

  • 1. Human Ntera2 cells as a predictive in vitro test system for developmental neurotoxicity.
    Stern M; Gierse A; Tan S; Bicker G
    Arch Toxicol; 2014 Jan; 88(1):127-36. PubMed ID: 23917397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells.
    Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF
    Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing.
    Moors M; Rockel TD; Abel J; Cline JE; Gassmann K; Schreiber T; Schuwald J; Weinmann N; Fritsche E
    Environ Health Perspect; 2009 Jul; 117(7):1131-8. PubMed ID: 19654924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach.
    Hogberg HT; Kinsner-Ovaskainen A; Coecke S; Hartung T; Bal-Price AK
    Toxicol Sci; 2010 Jan; 113(1):95-115. PubMed ID: 19651682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro developmental neurotoxicity screening assay for retinoic acid-induced neuronal differentiation using the human NT2/D1 cell line.
    Taylor MA; Kan HL; Gollapudi BB; Marty MS
    Neurotoxicology; 2019 Jul; 73():258-264. PubMed ID: 30980846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryotoxicity assessment of developmental neurotoxicants using a neuronal endpoint in the embryonic stem cell test.
    Baek DH; Kim TG; Lim HK; Kang JW; Seong SK; Choi SE; Lim SY; Park SH; Nam BH; Kim EH; Kim MS; Park KL
    J Appl Toxicol; 2012 Aug; 32(8):617-26. PubMed ID: 22131109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DNT-EST: a predictive embryonic stem cell-based assay for developmental neurotoxicity testing in vitro.
    Hayess K; Riebeling C; Pirow R; Steinfath M; Sittner D; Slawik B; Luch A; Seiler AE
    Toxicology; 2013 Dec; 314(1):135-47. PubMed ID: 24096155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Protocol for In Vitro High-Throughput Chemical Susceptibility Screening in Differentiating NT2 Stem Cells.
    Menzner AK; Gilbert DF
    Methods Mol Biol; 2017; 1601():61-70. PubMed ID: 28470517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.
    Aschner M; Ceccatelli S; Daneshian M; Fritsche E; Hasiwa N; Hartung T; Hogberg HT; Leist M; Li A; Mundi WR; Padilla S; Piersma AH; Bal-Price A; Seiler A; Westerink RH; Zimmer B; Lein PJ
    ALTEX; 2017; 34(1):49-74. PubMed ID: 27452664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omnisphero: a high-content image analysis (HCA) approach for phenotypic developmental neurotoxicity (DNT) screenings of organoid neurosphere cultures in vitro.
    Schmuck MR; Temme T; Dach K; de Boer D; Barenys M; Bendt F; Mosig A; Fritsche E
    Arch Toxicol; 2017 Apr; 91(4):2017-2028. PubMed ID: 27722930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human stem cell-based model for identifying adverse effects of organic and inorganic chemicals on the developing nervous system.
    Buzanska L; Sypecka J; Nerini-Molteni S; Compagnoni A; Hogberg HT; del Torchio R; Domanska-Janik K; Zimmer J; Coecke S
    Stem Cells; 2009 Oct; 27(10):2591-601. PubMed ID: 19609937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How neurobehavior and brain development in alternative whole-organism models can contribute to prediction of developmental neurotoxicity.
    Collins ES; Hessel EVS; Hughes S
    Neurotoxicology; 2024 May; 102():48-57. PubMed ID: 38552718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole genome microarray analysis of neural progenitor C17.2 cells during differentiation and validation of 30 neural mRNA biomarkers for estimation of developmental neurotoxicity.
    Attoff K; Gliga A; Lundqvist J; Norinder U; Forsby A
    PLoS One; 2017; 12(12):e0190066. PubMed ID: 29261810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
    Li J; Settivari R; LeBaron MJ; Marty MS
    Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints.
    Bal-Price AK; Hogberg HT; Buzanska L; Lenas P; van Vliet E; Hartung T
    Neurotoxicology; 2010 Sep; 31(5):545-54. PubMed ID: 19969020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurospheres as a model for developmental neurotoxicity testing.
    Fritsche E; Gassmann K; Schreiber T
    Methods Mol Biol; 2011; 758():99-114. PubMed ID: 21815061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
    Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
    Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).
    Terron A; Bennekou SH
    Toxicol Appl Pharmacol; 2018 Sep; 354():19-23. PubMed ID: 29454059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
    Llorens J; Li AA; Ceccatelli S; Suñol C
    Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
    Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
    Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.